Autoplaque vs Rhythm360
AI Verdict
Choose Autoplaque if…
Choose Autoplaque if your primary need is precise, AI-driven quantitative analysis of coronary plaque and luminal stenosis directly from CT angiography images. This tool is ideal for cardiologists and radiologists seeking detailed, objective measurements to enhance heart attack risk prediction and guide treatment decisions based on anatomical plaque burden.
View Autoplaque →Choose Rhythm360 if…
Choose Rhythm360 if you require a comprehensive, cloud-based platform to aggregate and analyze cardiac monitoring data from diverse devices for ongoing patient management. This solution is best suited for clinics focused on remote patient monitoring, reducing alert fatigue, and streamlining administrative tasks like CPT code documentation across a large patient population with conditions like hypertension, heart failure, and arrhythmias.
View Rhythm360 →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Autoplaque | Rhythm360 |
|---|---|---|
| Pricing | Unknown | Flexible pricing model that scales with clinic size and platform usage. |
| Deployment | Workstation-based post-processing application, runs on Windows or Mac OS. | Cloud-based SaaS platform |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Unknown |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Rhythm360Rhythm360 offers a cloud-based SaaS platform with a HIPAA-compliant mobile application, providing greater flexibility and accessibility for clinicians. Its AI-driven alert triage also directly addresses alert fatigue, enhancing user experience. Autoplaque, being workstation-based, is inherently less flexible in modern clinical workflows.
Clinical Value
TieBoth tools offer significant, yet distinct, clinical value. Autoplaque, an FDA-cleared diagnostic aid, provides quantitative analysis of coronary plaques for heart attack risk prediction and treatment guidance, with studies demonstrating its prognostic value. Rhythm360 focuses on real-time management of chronic cardiac conditions, showing improved critical alert response times and reduced hospitalizations through optimized treatment.
Pricing & Value
Rhythm360Rhythm360 provides a transparent, flexible SaaS pricing model that scales with clinic size and usage, and explicitly details automated CPT code documentation and billing, which enhances revenue capture and offers a clear ROI. Autoplaque's pricing is not disclosed, making it impossible to evaluate its value proposition.
Enterprise Readiness
Rhythm360Rhythm360 demonstrates superior enterprise readiness with its cloud-based SaaS deployment, explicit HIPAA compliance, BAA availability, and extensive bi-directional EHR integration with major systems. Its vendor-neutral data aggregation across all major cardiac device OEMs further enhances its adaptability for large healthcare organizations. Autoplaque's workstation-based deployment and lack of specified compliance details make it less suitable for enterprise adoption.
Innovation
Rhythm360While Autoplaque offers innovative AI for precise diagnostic imaging analysis of coronary plaques, Rhythm360 demonstrates broader innovation by integrating AI across a wider spectrum of cardiac care. Its vendor-neutral data aggregation, AI-driven alert triage, predictive analytics for chronic disease management, and advanced data normalization techniques represent a more comprehensive and integrated approach to leveraging AI in cardiology.
Support & Docs
Rhythm360Rhythm360 clearly outlines robust support offerings, including optional 24/7/365 oversight by certified cardiac technicians and a comprehensive online knowledge base with support documentation and guides. Autoplaque only vaguely mentions a user manual for hardware specifications, with no other explicit support details found.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Autoplaque | Rhythm360 |
|---|---|---|
| Name | Autoplaque | Rhythm360 |
| Company | Cedars-Sinai Medical Center: AIM | RhythmScience |
| Primary Focus | Quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance. | Unifies cardiac monitoring data from various devices, providing actionable insights for hypertension, heart failure, and rhythm management, and reducing alert fatigue. |
| Core AI Functionality | AI-powered quantitative analysis of atherosclerotic plaque, detection and characterization of coronary artery plaque, measurement of luminal stenoses, automated vessel, plaque, and lumen segmentation. | AI-driven alert triage (80% faster response times, reduces alert fatigue), AI Data Normalization (API, HL7, XML, PDF parsing via computer vision), predictive algorithms for Heart Failure Management. |
| Data Input/Integration | CT Angiographic images (DICOM image data). | Vendor-neutral data aggregation from all major OEMs (Medtronic, Boston Scientific, Abbott, Biotronik), Bi-directional EHR integration (Epic, Cerner, Athenahealth, eClinicalWorks, GreenwayHealth, GE Centricity). |
| Specialties | Cardiology, Radiology | Cardiology |
Videos
Demos, reviews, and walkthroughs featuring Autoplaque and Rhythm360.